Informations générales (source: ClinicalTrials.gov)
Acute Heart Failure With Preserved Ejection Fraction - COngestion Discharge Evaluation: Evaluation de la Congestion à la Sortie d'Hospitalisation Pour Insuffisance Cardiaque aiguë à Fraction d'éjection préservée (AHF-CODE-P)
Interventional
N/A
Central Hospital, Nancy, France (Voir sur ClinicalTrials)
août 2020
août 2028
29 juin 2024
The AHF-CODE preserved study is a prospective, non-randomized, monocenter study performed
in patients with heart failure with preserved ejection fraction admitted for worsening
heart failure.
The main objective of the AHF-CODE preserved study is to identify congestion markers
(clinical, biological and ultrasound) at the end of hospitalization for acute heart
failure that are associated with the risk of all cause death or rehospitalization for
acute heart failure within 3 months of hospital discharge.
Etablissements
Les établissements hors Île-de-France dont les données sont issues de ClinicalTrials.gov Origine et niveau de fiabilité des données | |||||
---|---|---|---|---|---|
CHRU de Nancy - 54500 - Vandœuvre-lès-Nancy - France | Nicolas GIRERD, MD,PhD | Contact (sur clinicalTrials) |
Critères
Tous
Inclusion Criteria:
- Patients hospitalised for acute heart failure.
- Patient with preserved ejection fraction (FE ≥ 50%).
- Patients considered clinically discharging from hospitalisation for acute heart
failure.
- Age ≥18 years
- Patients having received complete information regarding the study design and having
signed their informed consent form.
- Patient affiliated to or beneficiary of a social security scheme.
- Patients hospitalised for acute heart failure.
- Patient with preserved ejection fraction (FE ≥ 50%).
- Patients considered clinically discharging from hospitalisation for acute heart
failure.
- Age ≥18 years
- Patients having received complete information regarding the study design and having
signed their informed consent form.
- Patient affiliated to or beneficiary of a social security scheme.
- Comorbidity for which the life expectancy is ≤ 3 months
- Dialysis patient (peritoneal dialysis or hemodialysis) or patients with glomerular
filtration rate <15 ml/min/m² at inclusion.
- History of lobectomy or pneumonectomy lung surgery
- Severe pulmonary or pleural pathology preventing reliable acquisition of lung
ultrasound images: severe emphysema, chronic pleurisy, pulmonary fibrosis, etc.
- Pregnant woman, parturient or nursing mother
- Adult person subject to a legal protection measure (guardianship, curatorship,
safeguard of justice)
- Adult person who is unable to give consent
- Person deprived of liberty by a judicial or administrative decision,
- Person subject to psychiatric care pursuant to Articles L. 3212-1 and L. 3213-1 of
the Public Health Code.